Targeting KRAS Inhibitor–Resistant Pancreatic Cancer with an MUC1-C Antibody–Drug Conjugate

克拉斯 癌症研究 胰腺癌 医学 耐火材料(行星科学) 免疫组织化学 病理 后天抵抗 癌症 细胞培养 结合 化疗 胰腺疾病 肿瘤科 癌细胞 抗药性 细胞生长 突变 放射治疗 内科学
作者
Hiroki Ozawa,Keiko Takahashi,Tomoki Motegi,Justine J. Jacobi,Atrayee Bhattacharya,Keisuke Shigeta,Shinkichi Takamori,Mai Onishi,Zhou Luan,Kazumasa Fukuda,Akihisa Ueno,Minoru Kitago,Hirofumi Kawakubo,Yuko Kitagawa,Dove Keith,John L. Muschler,Rosalie C. Sears,Mark D. Long,Joseph Douglas Mancias,Andrew J. Aguirre
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
卷期号:31 (24): 5246-5260 被引量:11
标识
DOI:10.1158/1078-0432.ccr-25-2333
摘要

PURPOSE: Treatment of pancreatic ductal adenocarcinoma (PDAC) has been advanced by the development of KRAS inhibitors. Despite this progress, PDAC invariably develop resistance to these agents through multiple mechanisms. In this study, we investigated the role of the oncogenic MUC1-C (M1C) protein in mediating the resistance of PDAC cells to KRAS inhibition. EXPERIMENTAL DESIGN: Three PDAC KRAS G12D-mutant cell lines, as well as patient-derived KRAS inhibitor-resistant organoids and patient-derived xenograft models, were investigated in these studies. An anti-M1C antibody-drug conjugate (ADC) was evaluated for in vitro and in vivo activity. Tumors from patients with PDAC were studied by single-cell RNA sequencing and IHC staining. RESULTS: The MUC1 gene is upregulated in PDAC KRAS G12D-mutant tumors. We report that treatment of PDAC cells with the KRAS G12D inhibitor MRTX1133 is associated with the induction of the M1C protein. Mechanistically, KRAS G12D inhibition induces M1C by activation of an M1C/NF-κB p65 autoinductive pathway. Our results further demonstrate that M1C drives resistance to MRTX1133 by activating the inflammatory IFN type I pathway. Targeting M1C genetically and pharmacologically thereby reverses MRTX1133 resistance and is synergistic in combination with MRTX1133 treatment. Of translational significance, we demonstrate that an anti-M1C ADC is highly effective against MRTX1133-resistant PDAC KRAS G12D cell lines and patient-derived organoid and patient-derived xenograft models. CONCLUSIONS: These findings demonstrate that M1C confers resistance of PDAC to KRAS G12D inhibition and identify M1C as a potential target for ADC treatment of patients with PDAC who are refractory to KRAS inhibitors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
坦率惊蛰发布了新的文献求助10
刚刚
烟花的应助被zhc采纳,获得10
1秒前
Maestro_S的应助被神秘墨镜男采纳,获得10
1秒前
1秒前
水煮电吹风的应助被笑哈哈采纳,获得10
1秒前
汉堡包的应助被晨烨采纳,获得10
1秒前
kkk完成签到,获得积分10
1秒前
神勇的绮烟完成签到,获得积分10
2秒前
超帅问枫完成签到,获得积分10
2秒前
li发布了新的文献求助50
2秒前
bkagyin的应助被12采纳,获得10
3秒前
真不爱学习完成签到 ,获得积分10
3秒前
howdream完成签到,获得积分20
3秒前
HF完成签到,获得积分10
3秒前
飞快的易烟完成签到,获得积分10
3秒前
小豆包发布了新的文献求助10
4秒前
4秒前
5秒前
甜甜圈完成签到,获得积分10
6秒前
科研通AI6.3的应助被曹大壮采纳,获得10
6秒前
难过板栗发布了新的文献求助10
6秒前
漂亮的浩阑完成签到,获得积分10
6秒前
Lucas的应助被lijie采纳,获得10
6秒前
三吉完成签到,获得积分10
6秒前
6秒前
不错吧发布了新的文献求助20
6秒前
充电宝的应助被橹穆采纳,获得10
6秒前
zhazhao发布了新的文献求助10
7秒前
华仔的应助被serein采纳,获得10
7秒前
7秒前
7秒前
7秒前
只要一点点的应助被舒心易烟采纳,获得10
8秒前
科研通AI65的应助被Mmxn采纳,获得10
8秒前
8秒前
9秒前
9秒前
Teletubbies的应助被Gally采纳,获得20
9秒前
田様的应助被zhangyaoyang采纳,获得10
10秒前
甜甜圈发布了新的文献求助10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183046
求助须知:如何正确求助?哪些是违规求助? 9572370
关于积分的说明 21824411
捐赠科研通 7779694
什么是DOI,文献DOI怎么找? 3433792
关于科研通互助平台的介绍 2558024
邀请新用户注册赠送积分活动 2479971